Human T Lymphotropic Virus Type 1 SU Residue 195 Plays a Role in Determining the Preferential CD4 + T Cell Immortalization/Transformation Tropism

Author:

Kannian Priya12,Fernandez Soledad34,Jones Kathryn S.5,Green Patrick L.1263

Affiliation:

1. Center for Retrovirus Research, The Ohio State University, Columbus, Ohio, USA

2. Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA

3. Comprehensive Cancer Center and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA

4. Center for Biostatistics, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, Ohio, USA

5. Basic Science Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA

6. Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio, USA

Abstract

ABSTRACT Human T lymphotropic virus type 1 (HTLV-1) mainly causes adult T cell leukemia and predominantly immortalizes/transforms CD4 + T cells in culture. HTLV-2 is aleukemic and predominantly immortalizes/transforms CD8 + T cells in culture. We have shown previously that the viral envelope is the genetic determinant of the differential T cell tropism in culture. The surface component (SU) of the HTLV-1 envelope is responsible for binding to the cellular receptors for entry. Here, we dissect the HTLV-1 SU further to identify key domains that are involved in determining the immortalization tropism. We generated HTLV-1 envelope recombinant virus containing the HTLV-2 SU domain. HTLV-1/SU2 was capable of infecting and immortalizing freshly isolated peripheral blood mononuclear cells in culture. HTLV-1/SU2 shifted the CD4 + T cell immortalization tropism of wild-type HTLV-1 (wtHTLV-1) to a CD8 + T cell preference. Furthermore, a single amino acid substitution, N195D, in HTLV-1 SU (Ach.195) resulted in a shift to a CD8 + T cell immortalization tropism preference. Longitudinal phenotyping analyses of the in vitro transformation process revealed that CD4 + T cells emerged as the predominant population by week 5 in wtHTLV-1 cultures, while CD8 + T cells emerged as the predominant population by weeks 4 and 7 in wtHTLV-2 and Ach.195 cultures, respectively. Our results indicate that SU domain independently influences the preferential T cell immortalization tropism irrespective of the envelope counterpart transmembrane (TM) domain. We further showed that asparagine at position 195 in HTLV-1 SU is involved in determining this CD4 + T cell immortalization tropism. The slower emergence of the CD8 + T cell predominance in Ach.195-infected cultures suggests that other residues/domains contribute to this tropism preference.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference39 articles.

1. LairmoreM FranchiniG. 2007. Human T-cell leukemia virus types 1 and 2, p 2071–2106. In FieldsB KnipeD HowleyP ChanockR MonathT MelnickJ RoizmanB StrausS (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.

2. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription;Halin M;Blood,2009

3. Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis;Kannian P;Viruses,2010

4. The HBZ gene, a key player in HTLV-1 pathogenesis;Matsuoka M;Retrovirology,2009

5. HTLV-2 APH-2 is dispensable for in vitro immortalization, but functions to repress early viral replication in vivo;Yin H;J. Virol,2012

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3